Clinical Trial Update: Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of sirolimus on non-melanoma skin cancer in kidney transplant recipients has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Rapamune (sirolimus)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Skin Neoplasms, Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2012-03-23